3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Hepatocellular
20
Carcinoma, Renal Cell
16
Parkinson Disease 4, Autosomal Dominant Lewy Body
10
Endometrial Neoplasms
7
Neoplasms
4
Biliary Tract Neoplasms
4
Uterine Cervical Neoplasms
3
Neuroendocrine Tumors
3
Melanoma
3
Liver Neoplasms
3
Vulvar Neoplasms
2
Triple Negative Breast Neoplasms
2
Thyroid Neoplasms
2
Stomach Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Neoplasm Metastasis
2
Colorectal Neoplasms
2
Cholangiocarcinoma
2
Carcinoma, Non-Small-Cell Lung
2
Brain Neoplasms
2
von Hippel-Lindau Disease
1
Thyroid Carcinoma, Anaplastic
1
Small Cell Lung Carcinoma
1
Skin Neoplasms
1
Penile Neoplasms
1
Multiple Endocrine Neoplasia Type 1
1
Lung Neoplasms
1
Kidney Neoplasms
1
Interventions
Specimen Handling
5
Magnetic Resonance Spectroscopy
5
Cisplatin
4
trastuzumab deruxtecan
3
Platinum
3
Docetaxel
3
Carboplatin
3
Biopsy
3
pembrolizumab
2
entrectinib
2
darolutamide
2
Trastuzumab
2
Radiotherapy, Intensity-Modulated
2
Leuprolide
2
Goserelin
2
Ado-Trastuzumab Emtansine
2
1,2-diaminocyclohexaneplatinum II citrate
2
zanidatamab
1
trastuzumab biosimilar HLX02
1
sacituzumab govitecan
1
pyrotinib
1
pertuzumab
1
luprolide acetate gel depot
1
larotrectinib
1
enfortumab vedotin
1
dehydroftorafur
1
ceralasertib
1
camrelizumab
1
bicalutamide
1
apatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Salivary Gland Neoplasms
×
lenvatinib
×
90 days
×
Clear all
No trials found.